Source: Virtual Congress 2021 – CCC Paediatric respiratory diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hillson (Great Kingshill, United Kingdom). One bug, many drugs. Virtual Congress 2021 – CCC Paediatric respiratory diseases

Member's Comments

No comment yet.

Related content which might interest you: New (or old?) drugs for bad bugs Source: International Congress 2015 – Antibiotic resistance in respiratory infections Year: 2015 Allergenicity of wasps and mites used for biological control in greenhouses Source: Eur Respir J 2005; 26: Suppl. 49, 598s Year: 2005 Allergenicity of the predator mites Amblyseius cucumeris and Phytoseiulus persimilis Source: Annual Congress 2008 - COPD and other environment-related lung diseases Year: 2008 New drugs and drug regimens in the treatment of chronic and MDR-TB - what is on the horizon? Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Pulmonary infections: what to do when it's a bug that you do not know Source: Eur Respir J 2003; 21: 201 Year: 2003 The side-effects of TB therapy: myth and reality Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005 Unlicensed and off-label prescription of respiratory drugs to children Source: Eur Respir J 2004; 23: 310-313 Year: 2004 A new treatment (Passion fruit) for asthma Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006 Is iroko (chlorophora excelsa) a sensitizing wood at the work place? Source: Eur Respir J 2001; 18: Suppl. 33, 282s Year: 2001 New and repurposed drugs Source: Eur Respir Monogr 2018; 82: 179-204 Year: 2018 High rates of resistance to second line drugs are routinely encountered in Mumbai,India for XDR-TB;highlighting the need for new agents. Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 How France has hijacked tobacco price increase, an effective tool of tobacco control, to increase the financial profits Source: Annual Congress 2012 - Tobacco use and cessation Year: 2012 Rational use of tuberculosis drugs to prevent the development of drug resistance Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Source: Eur Respir J 2012; 39: 802-804 Year: 2012 Medical surveillance of workers exposed to mites and moths in a biological pesticides plant Source: Annual Congress 2013 –Occupational respiratory diseases: obstructive, interstitial lung diseases and methods of diagnosis Year: 2013 Occurrence of dust lice species (Psocoptera) in German urban dwellings Source: Eur Respir J 2001; 18: Suppl. 33, 435s Year: 2001 Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey Source: Eur Respir J 2015; 45: 1081-1088 Year: 2015